| Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016 A Rhodes, LE Evans, W Alhazzani, MM Levy, M Antonelli, R Ferrer, ... Intensive care medicine 43, 304-377, 2017 | 10378 | 2017 |
| Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review WJ Wiersinga, A Rhodes, AC Cheng, SJ Peacock, HC Prescott Jama 324 (8), 782-793, 2020 | 5894 | 2020 |
| Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 L Evans, A Rhodes, W Alhazzani, M Antonelli, CM Coopersmith, C French, ... Critical care medicine 49 (11), e1063-e1143, 2021 | 3663 | 2021 |
| Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability PJM Brouwer, TG Caniels, K van der Straten, JL Snitselaar, Y Aldon, ... Science 369 (6504), 643-650, 2020 | 1162 | 2020 |
| Melioidosis WJ Wiersinga, BJ Currie, SJ Peacock New England Journal of Medicine 367 (11), 1035-1044, 2012 | 923 | 2012 |
| Inflammation, endothelium, and coagulation in sepsis M Schouten, WJ Wiersinga, M Levi, T van der Poll Journal of Leucocyte Biology 83 (3), 536-545, 2008 | 886 | 2008 |
| The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia TJ Schuijt, JM Lankelma, BP Scicluna, FS e Melo, JJTH Roelofs, ... Gut 65 (4), 575-583, 2016 | 727 | 2016 |
| Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei WJ Wiersinga, T Van der Poll, NJ White, NP Day, SJ Peacock Nature Reviews Microbiology 4 (4), 272-282, 2006 | 725 | 2006 |
| Melioidosis WJ Wiersinga, HS Virk, AG Torres, BJ Currie, SJ Peacock, DAB Dance, ... Nature reviews Disease primers 4 (1), 1-22, 2018 | 598 | 2018 |
| Host innate immune responses to sepsis WJ Wiersinga, SJ Leopold, DR Cranendonk, T van Der Poll Virulence 5 (1), 36-44, 2014 | 533 | 2014 |
| The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity MF Osuchowski, MS Winkler, T Skirecki, S Cajander, M Shankar-Hari, ... The Lancet Respiratory Medicine 9 (6), 622-642, 2021 | 475 | 2021 |
| Host–pathogen interaction in invasive salmonellosis HK De Jong, CM Parry, T van der Poll, WJ Wiersinga Public Library of Science 8 (10), e1002933, 2012 | 426 | 2012 |
| The immunology of sepsis T van der Poll, M Shankar-Hari, WJ Wiersinga Immunity 54 (11), 2450-2464, 2021 | 347 | 2021 |
| Time‐course of cytokines during delirium in elderly patients with hip fractures BC Van Munster, JC Korevaar, AH Zwinderman, M Levi, WJ Wiersinga, ... Journal of the American Geriatrics Society 56 (9), 1704-1709, 2008 | 271 | 2008 |
| Current gaps in sepsis immunology: new opportunities for translational research I Rubio, MF Osuchowski, M Shankar-Hari, T Skirecki, MS Winkler, ... The Lancet infectious diseases 19 (12), e422-e436, 2019 | 268 | 2019 |
| Significant correlation between the infant gut microbiome and rotavirus vaccine response in rural Ghana VC Harris, G Armah, S Fuentes, KE Korpela, U Parashar, JC Victor, J Tate, ... The Journal of infectious diseases 215 (1), 34-41, 2017 | 268 | 2017 |
| A guide to immunotherapy for COVID-19 FL van de Veerdonk, E Giamarellos-Bourboulis, P Pickkers, L Derde, ... Nature medicine 28 (1), 39-50, 2022 | 264 | 2022 |
| The impact of diabetes on the pathogenesis of sepsis G Koh, SJ Peacock, T Van Der Poll, WJ Wiersinga European journal of clinical microbiology & infectious diseases 31, 379-388, 2012 | 257 | 2012 |
| The role of the gut microbiota in sepsis BW Haak, WJ Wiersinga The lancet Gastroenterology & hepatology 2 (2), 135-143, 2017 | 250 | 2017 |
| Recommendations for antibacterial therapy in adults with COVID-19–an evidence based guideline E Sieswerda, MGJ De Boer, MMJ Bonten, WG Boersma, RE Jonkers, ... Clinical microbiology and infection 27 (1), 61-66, 2021 | 248 | 2021 |
